Date | Time | Source | Headline | Symbol | Company |
05/10/2024 | 7:17AM | GlobeNewswire Inc. | Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024 | NYSE:EBS | Emergent Biosolutions Inc |
05/01/2024 | 4:57PM | GlobeNewswire Inc. | Emergent BioSolutions Reports First Quarter 2024 Financial Results | NYSE:EBS | Emergent Biosolutions Inc |
05/01/2024 | 4:10PM | GlobeNewswire Inc. | Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position | NYSE:EBS | Emergent Biosolutions Inc |
05/01/2024 | 11:03AM | GlobeNewswire Inc. | Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone | NYSE:EBS | Emergent Biosolutions Inc |
04/30/2024 | 5:26PM | GlobeNewswire Inc. | Emergent BioSolutions Announces Amendment to its Existing Credit Facility | NYSE:EBS | Emergent Biosolutions Inc |
04/22/2024 | 8:05AM | GlobeNewswire Inc. | Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024 | NYSE:EBS | Emergent Biosolutions Inc |
04/01/2024 | 8:00AM | GlobeNewswire Inc. | Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive | NYSE:EBS | Emergent Biosolutions Inc |
03/28/2024 | 8:15AM | GlobeNewswire Inc. | Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis | NYSE:EBS | Emergent Biosolutions Inc |
03/25/2024 | 8:05AM | GlobeNewswire Inc. | Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility | NYSE:EBS | Emergent Biosolutions Inc |
03/08/2024 | 4:21PM | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NYSE:EBS | Emergent Biosolutions Inc |
03/07/2024 | 8:31PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:EBS | Emergent Biosolutions Inc |
03/06/2024 | 4:31PM | GlobeNewswire Inc. | Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results | NYSE:EBS | Emergent Biosolutions Inc |
03/06/2024 | 4:15PM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:EBS | Emergent Biosolutions Inc |
03/06/2024 | 6:02AM | IH Market News | U.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices Climb | NYSE:EBS | Emergent Biosolutions Inc |
03/04/2024 | 6:43PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:EBS | Emergent Biosolutions Inc |
03/04/2024 | 6:43PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:EBS | Emergent Biosolutions Inc |
03/04/2024 | 6:42PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:EBS | Emergent Biosolutions Inc |
02/29/2024 | 7:00AM | GlobeNewswire Inc. | Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024 | NYSE:EBS | Emergent Biosolutions Inc |
02/27/2024 | 8:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:EBS | Emergent Biosolutions Inc |
02/27/2024 | 8:28PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:EBS | Emergent Biosolutions Inc |
02/21/2024 | 7:25AM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:EBS | Emergent Biosolutions Inc |
02/21/2024 | 7:00AM | GlobeNewswire Inc. | Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO | NYSE:EBS | Emergent Biosolutions Inc |
01/11/2024 | 7:41AM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:EBS | Emergent Biosolutions Inc |
01/09/2024 | 8:40AM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:EBS | Emergent Biosolutions Inc |
01/09/2024 | 7:30AM | GlobeNewswire Inc. | Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024 | NYSE:EBS | Emergent Biosolutions Inc |
12/27/2023 | 6:08AM | IH Market News | Wall Street Highlights: Apple Appeals Watch Ban, Tesla to Launch Updated Model Y, and More | NYSE:EBS | Emergent Biosolutions Inc |
12/11/2023 | 5:22PM | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NYSE:EBS | Emergent Biosolutions Inc |
12/11/2023 | 7:24AM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NYSE:EBS | Emergent Biosolutions Inc |
11/28/2023 | 7:15AM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:EBS | Emergent Biosolutions Inc |
11/28/2023 | 6:59AM | GlobeNewswire Inc. | Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted) | NYSE:EBS | Emergent Biosolutions Inc |